Razavi International Journal of Medicine

Published by: Kowsar

Antimicrobial Susceptibility Pattern of Staphylococcus aureus Isolates Against Newly Marketed Antibiotics: A Report From Imam Reza Hospital of Mashhad, Iran

Arash Arianpoor 1 , 2 , Fatemeh Estaji 1 , 2 , Mahboubeh Naderinasab 3 , * and Emran Askari 1 , 2
Authors Information
1 Student Research Committee, Mashhad University of Medical Sciences, Mashhad, IR Iran
2 Mashhad Medical Microbiology Student Research Group, Mashhad University of Medical Sciences, Mashhad, IR Iran
3 Microbiology Laboratory, Central Laboratory, Imam Reza Hospital, Mashhad, IR Iran
Article information
  • Razavi International Journal of Medicine: November 1, 2015, 3 (4); e31568
  • Published Online: November 29, 2015
  • Article Type: Research Article
  • Received: July 15, 2015
  • Revised: August 28, 2015
  • Accepted: September 11, 2015
  • DOI: 10.17795/rijm31568

To Cite: Arianpoor A, Estaji F, Naderinasab M, Askari E. Antimicrobial Susceptibility Pattern of Staphylococcus aureus Isolates Against Newly Marketed Antibiotics: A Report From Imam Reza Hospital of Mashhad, Iran, Razavi Int J Med. 2015 ; 3(4):e31568. doi: 10.17795/rijm31568.

Abstract
Copyright © 2015, Razavi Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Cookson B, Bonten MJ, Mackenzie FM, Skov RL, Verbrugh HA, Tacconelli E, et al. Meticillin-resistant Staphylococcus aureus (MRSA): screening and decolonisation. Int J Antimicrob Agents. 2011; 37(3): 195-201[DOI][PubMed]
  • 2. Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011; 52(3)-55[DOI][PubMed]
  • 3. Shlaes DM, Spellberg B. Overcoming the challenges to developing new antibiotics. Curr Opin Pharmacol. 2012; 12(5): 522-6[DOI][PubMed]
  • 4. van Hal SJ, Fowler VG. Is it time to replace vancomycin in the treatment of methicillin-resistant Staphylococcus aureus infections? Clin Infect Dis. 2013; 56(12): 1779-88[DOI][PubMed]
  • 5. Askari E, Tabatabai SM, Arianpoor A, Nasab MN. VanA-positive vancomycin–resistant Staphylococcus aureus: systematic search and review of reported cases. Infect Dis Clin Prac. 2013; 21(2): 91-3
  • 6. Rossi F, Diaz L, Wollam A, Panesso D, Zhou Y, Rincon S, et al. Transferable vancomycin resistance in a community-associated MRSA lineage. N Engl J Med. 2014; 370(16): 1524-31[DOI][PubMed]
  • 7. Hiramatsu K. Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Infect Dis. 2001; 1(3): 147-55[DOI][PubMed]
  • 8. Richter SS, Diekema DJ, Heilmann KP, Dohrn CL, Crispell EK, Riahi F, et al. Activities of vancomycin, ceftaroline, and mupirocin against Staphylococcus aureus isolates collected in a 2011 national surveillance study in the United States. Antimicrob Agents Chemother. 2014; 58(2): 740-5[DOI][PubMed]
  • 9. Yu F, Lu C, Liu Y, Sun H, Shang Y, Ding Y, et al. Emergence of quinupristin/dalfopristin resistance among livestock-associated Staphylococcus aureus ST9 clinical isolates. Int J Antimicrob Agents. 2014; 44(5): 416-9[DOI][PubMed]
  • 10. Askari E, Soleymani F, Arianpoor A, Tabatabai SM, Amini A, Naderinasab M. Epidemiology of mecA-Methicillin Resistant Staphylococcus aureus (MRSA) in Iran: A Systematic Review and Meta-analysis. Iran J Basic Med Sci. 2012; 15(5): 1010-9[PubMed]
  • 11. Sanchez Garcia M, De la Torre MA, Morales G, Pelaez B, Tolon MJ, Domingo S, et al. Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit. JAMA. 2010; 303(22): 2260-4[DOI][PubMed]
  • 12. Gu B, Kelesidis T, Tsiodras S, Hindler J, Humphries RM. The emerging problem of linezolid-resistant Staphylococcus. J Antimicrob Chemother. 2013; 68(1): 4-11[DOI][PubMed]
  • 13. Ruzbahani M, Rahdar HA, Babaei Z, Rezaeyan MH, Jafari M, Rezai M. Identification of Antibiotic Resistance Patterns of Methicillin-Resistant Staphylococcus Aureus Isolates from Patients in Selected Hospitals in Isfahan. Glob J Med Res Stud. 2014; 1(2): 37-40
  • 14. Shahsavan S, Emaneini M, Noorazar Khoshgnab B, Khoramian B, Asadollahi P, Aligholi M, et al. A high prevalence of mupirocin and macrolide resistance determinant among Staphylococcus aureus strains isolated from burnt patients. Burns. 2012; 38(3): 378-82[DOI][PubMed]
  • 15. Dibah S, Arzanlou M, Jannati E, Shapouri R. Prevalence and antimicrobial resistance pattern of methicillin resistant Staphylococcus aureus (MRSA) strains isolated from clinical specimens in Ardabil, Iran. Iran J Microbiol. 2014; 6(3): 163-8[PubMed]
  • 16. Rahimi F, Bouzari M, Katouli M, Pourshafie MR. Antibiotic resistance pattern of methicillin resistant and methicillin sensitive Staphylococcus aureus isolates in Tehran, Iran. Jundishapur J Microbiol. 2013; 6(2): 144-9
  • 17. Luh KT, Hsueh PR, Teng LJ, Pan HJ, Chen YC, Lu JJ, et al. Quinupristin-dalfopristin resistance among gram-positive bacteria in Taiwan. Antimicrob Agents Chemother. 2000; 44(12): 3374-80[PubMed]
  • 18. Kali A, Stephen S, Umadevi S, Kumar S. Detection of quinupristin-dalfopristin resistance in methicillin-resistant Staphylococcus aureus in South India. Indian J Pathol Microbiol. 2013; 56(1): 73-4[DOI][PubMed]
  • 19. Hassanzadeh S, Pourmand MR, Hadadi A, Nourijeylani K, Yousefi M, Mashhadi R, et al. Frequency and Antimicrobial Resistance Patterns of Methicillin-Resistant Staphylococcus aureus in Tehran. J Med Bacteriol. 2013; 2(3, 4): 41-6
  • 20. Yin LY, Lazzarini L, Li F, Stevens CM, Calhoun JH. Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model. J Antimicrob Chemother. 2005; 55(6): 995-1002[DOI][PubMed]
  • 21. Florescu I, Beuran M, Dimov R, Razbadauskas A, Bochan M, Fichev G, et al. Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study. J Antimicrob Chemother. 2008; 62 Suppl 1-28[DOI][PubMed]
  • 22. Verkade EJ, Verhulst CJ, Huijsdens XW, Kluytmans JA. In vitro activity of tigecycline against methicillin-resistant Staphylococcus aureus, including livestock-associated strains. Eur J Clin Microbiol Infect Dis. 2010; 29(5): 503-7[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments